Table 4.4 Reported cases of laboratory-confirmed, chronic (past or present) hepatitis C infection, by sex, race/ethnicity, age group, and case criteria — Enhanced Viral Hepatitis Surveillance Sites, 2010
|
Category
|
CO No. (%) |
CT No. (%) |
MN No. (%) |
NM No. (%) |
NY State No. (%) |
NY City No. (%) |
OR No. (%) |
San Francisco No. (%) |
Total No. (%) |
|---|---|---|---|---|---|---|---|---|---|
|
Sex
|
|||||||||
|
Female
|
1063 (34.4) |
1029 (33.4) |
664 (37.5) |
857 (29.1) |
2155 (32.8) |
3470 (34.6) |
1247 (36.5) |
537 (31.8) |
11022 (32.3) |
|
Male
|
2030 (65.6) |
2053 (66.6) |
1092 (61.6) |
2086 (70.9) |
4410 (67.1) |
6510 (65.0) |
2157 (63.2) |
1125 (66.6) |
21463 (62.8) |
|
Unknown/Miss
|
0 (0.0) |
0 (0.0) |
17 (1.0) |
1 (0.0) |
4 (0.1) |
41 (0.4) |
11 (0.3) |
28 (1.7) |
102 (0.3) |
|
Race/Ethnicity*
|
|||||||||
|
AI / AN
|
26 (0.8) |
5 (0.2) |
98 (5.5) |
66 (2.2) |
29 (0.4) |
0 (0.0 ) |
53 (1.6) |
12 (0.7) |
289 (0.9) |
|
API
|
25 (0.8) |
39 (1.3) |
47 (2.7) |
1 (0.0) |
79 (1.2) |
145 (1.5) |
15 (0.4) |
87 (5.2) |
438 (1.3) |
|
Black
|
180 (5.8) |
365 (11.8) |
196 (11.1) |
11 (0.4) |
851 (13.0) |
1175 (11.7) |
76 (2.2) |
355 (21.0) |
3209 (9.4) |
|
White
|
1089 (35.2) |
1274 (41.3) |
744 (42.0) |
278 (9.4) |
2641 (40.2) |
697 (7.0) |
1095 (32.1) |
537 (31.8) |
8355 (24.5) |
|
Hispanic
|
381 (12.3) |
501 (16.3) |
52 (2.9) |
344 (11.7) |
653 (9.9) |
338 (3.4) |
57 (1.7) |
125 (7.4) |
2451 (7.2) |
|
Other
|
13 (0.4) |
5 (0.2) |
23 (1.3) |
0 (0.0) |
45 (0.8) |
295 (2.9) |
24 (0.7) |
25 (1.5) |
437 (1.3) |
|
Unknown / Missing
|
1379 (44.6) |
893 (29.0) |
613 (34.6) |
2244 (76.2) |
2264 (34.5) |
7371 (73.6) |
2095 (63.1) |
549 (32.5) |
17408 (50.9) |
|
Age group (yrs)
|
|||||||||
|
0-14
|
14 (0.5) |
5 (0.2) |
6 (0.3) |
6 (0.2) |
9 (0.1) |
71 (0.7) |
14 (0.4) |
4 (0.2) |
129 (0.4) |
|
15-24
|
111 (3.6) |
147 (4.8) |
108 (6.1) |
371 (12.6) |
336 (5.1) |
308 (3.1) |
84 (2.5) |
20 (1.2) |
1485 (4.3) |
|
25-39
|
590 (19.1) |
564 (18.3) |
265 (15.0) |
994 (33.8) |
1248 (19.0) |
1760 (17.6) |
492 (14.4) |
200 (11.8) |
6113 (17.9) |
|
40-54
|
1428 (46.2) |
1412 (45.8) |
787 (44.4) |
1078 (36.6) |
2650 (40.3) |
3714 (37.1) |
1609 (47.1) |
712 (42.1) |
13390 (39.2) |
|
55+
|
941 (30.4) |
954 (31.0) |
606 (34.2) |
495 (16.8) |
2323 (35.4) |
4168 (41.6) |
1209 (35.4) |
746 (44.1) |
11442 (33.5) |
|
Missing
|
9 (0.3) |
0 (0.0) |
1 (0.1) |
0 (0.0) |
3 (0.1) |
0 (0.0) |
7 (0.2) |
8 (0.5) |
28 (0.1) |
|
Case criteria†
|
|||||||||
|
Anti-HCV and supplemental test
|
222 (7.2) |
163 (5.3) |
240 (13.5) |
U (U) |
689 (10.5) |
933 (9.3) |
171 ( 5.01) |
21 (1.2) |
2439 (7.1) |
|
RIBA
|
351 (11.4) |
240 (7.8) |
403 (22.7) |
U (U) |
936 (14.3) |
1449 (14.5) |
334 ( 9.78) |
54 (3.2) |
3767 (11.0) |
|
HCV RNA
|
1594 (51.5) |
770 (25.0) |
1256 (70.8) |
U (U) |
4392 (66.9) |
4753 (47.4) |
1746 (51.13) |
1150 (68.1) |
15661 (45.8) |
|
Genotype
|
838 (27.1) |
128 (4.2) |
626 (35.3) |
U (U) |
2291 (34.9) |
2649 (26.4) |
423 (12.4) |
554 (32.8) |
7509 (22.0) |
|
Anti-HCV and
s/co ratio |
1701 (55.0) |
2377 (77.1) |
633 (35.7) |
U (U) |
3806 (57.9) |
7993 (79.8) |
1424 (41.7) |
1002 (59.3) |
18936 (55.4) |
|
Total new
reported cases |
3,093 | 3,082 | 1,773 | 2,944 | 6,569 | 10,021 | 3,415 | 1,690 | 32,587 |
|
Estimated 2010
population |
5,029,196 | 3,574,097 | 5,303,925 | 2,059,179 | 11,202,969 | 8,175,133 | 3,831,074 | 805,235 | 39,980,808 |
|
Rate per 100,000 population
|
62.5 | 86.2 | 33.4 | 143.0 | 58.6 | 122.6 | 89.1 | 209.9 | 81.5 |
*Categorized in the following order: 1) Hispanic; 2) AI/AN; 3) API; 4) Black; 5) White; 6) Other;
† Cases can be reported with more than one laboratory test result
U=No data available for reporting.
Page last reviewed: June 14, 2012